Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning

Human Molecular Genetics

Volumn 14, Issue 13, 2005, Pages 1727-1743

  Nixon, Susan J ^a   Wegner, Jeremy ^b   Ferguson, Charles ^a   Méry, Pierre François ^a,d   Hancock, John F ^a   Currie, Peter D ^c   Key, Brian ^a   Westerfield, Monte ^b   Parton, Robert G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF OREGON   (United States)

^c VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^d CCIPE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; DYSTROGLYCAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL COUNT; CELL DIFFERENTIATION; CELL FUSION; CELL ISOLATION; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; EMBRYO SEGMENTATION; FACE MUSCLE; GENETIC CONSERVATION; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE DISEASE; MUSCLE FIBRIL; MYOBLAST; NONHUMAN; NOTOCHORD; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SARCOLEMMA; SEQUENCE HOMOLOGY; SOMITE; UPREGULATION; ZEBRA FISH;

AMINO ACID SEQUENCE; ANIMALS; CAVEOLIN 3; CAVEOLINS; CELL DIFFERENTIATION; CELL FUSION; EMBRYO, NONMAMMALIAN; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; MYOFIBRILS; ZEBRAFISH;

ANIMALIA; DANIO RERIO;

EID: 24144480448     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi179     Document Type: Article

References (74)

1. Rothberg, K.G., Heuser, J.E., Donzell, W.C., Ying, Y.S., Glenney, J.R. and Anderson, R.G. (1992) Caveolin, a protein component of caveolae membrane coats. Cell, 68, 673-682.
2. Scherer, P.E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H.F. and Lisanti, M.P. (1996) Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl Acad. Sci. USA 93, 131-135.
3. Tang, Z., Scherer, P.E., Okamoto, T., Song, K., Chu, C., Kohtz, D.S., Nishimoto, L, Lodish, H.F. and Lisanti, M.P. (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem., 271, 2255-2261.
4. Way, M. and Parton, R.G. (1995) M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett., 376, 108-112.
5. Carver, L.A. and Schnitzer, J.E. (2003) Caveolae: Mining little caves for new cancer targets. Nat. Rev. Cancer, 3, 571-581.
6. Repetto, S., Bado, M., Broda, P., Lucania, G., Masetti, E., Sotgia, F., Carbone, I., Pavan, A., Bonilla, E., Cordone, G. et al. (1999) Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem. Biophys. Res. Commun., 261, 547-550.
7. Vaghy, P.L., Fang, J., Wu, W. and Vaghy, L.P. (1998) Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett., 431, 125-127.
8. Bonilla, E., Fischbeck, K. and Schotland, D.L. (1981) Freeze-fracture studies of muscle caveolae in human muscular dystrophy. Am. J. Pathol., 104, 167-173.
9. Razani, B., Engelman, J.A., Wang, X.B., Schubert, W., Zhang, X.L., Marks, C.B., Macaluso, F., Russell, R.G., Li, M., Pestell, R.G. et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem., 276, 38121-38138.
10. Hagiwara, Y., Sasaoka, T., Araishi, K., Imamura, M., Yorifuji, H., Nonaka, I., Ozawa, E. and Kikuchi, T. (2000) Caveolin-3 deficiency causes muscle degeneration in mice. Hum. Mol. Genet., 9, 3047-3054.
11. Galbiati, F., Engelman, J.A., Volonte, D., Zhang, X.L., Minetti, C., Li, M., Hou, H., Jr. Kneitz, B., Edelmann, W. and Lisanti, M.P. (2001) Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem., 276, 21425-21433.
12. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F.C. et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science, 293, 2449-2452.
13. Galbiati, F., Volonte, D., Chu, J.B., Li, M., Fine, S.W., Fu, M., Bermudez, J., Pedemonte, M., Weidenheim, K.M., Pestell, R.G. et al. (2000) Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc. Natl Acad. Sci. USA, 97, 9689-9694.
14. Fischer, D., Schroers, A., Blumcke, I., Urbach, H., Zerres, K., Mortier, W., Vorgerd, M. and Schroder, R. (2003) Consequences of a novel caveolin-3 mutation in a large German family. Ann. Neurol., 53 233-241.
15. McNally, E.M., de Sa Moreira, E., Duggan, D.J., Bonnemann, C.G., Lisanti, M.P., Lidov, H.G., Vainzof, M., Passos-Bruno, M.R., Hoffman, E.P., Zatz, M. et al. (1998) Caveolin-3 in muscular dystrophy. Hum. Mol. Genet., 7, 871-877.
16. Merlini, L., Carbone, I., Capanni, C., Sabatelli, P., Tortorelli, S., Sotgia, F., Lisanti, M.P., Bruno, C. and Minetti, C. (2002) Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J. Neurol. Neurosurg. Psychiatry, 73, 65-67.
17. Tateyama, M., Aoki, M., Nishino, I., Hayashi, Y.K., Sekiguchi, S., Shiga, Y., Takahashi, T., Onodera, Y., Haginoya, K., Kobayashi, K. et al. (2002) Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology, 58, 323-325.
18. Kubisch, C., Schoser, B.G., von During, M., Betz, R.C., Goebel, H.H., Zahn, S., Ehrbrecht, A., Aasly, J., Schroers, A., Popovic, N. et al. (2003) Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann. Neurol., 53, 512-520.
19. Herrmann, R., Straub, V., Blank, M., Kutzick, C., Franke, N., Jacob. E.N., Lenard, H.G., Kroger, S. and Voit, T. (2000) Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum. Mol. Genet., 9, 2335-2340.
20. Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti. E., Mazzocco, M., Egeo, A., Donati, M.A. et al. (1998) Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet., 18, 365-368.
21. Vorgerd, M., Ricker, K., Ziemssen, F., Kress, W., Goebel, H.H., Nix, W.A., Kubisch, C., Schoser, B.G. and Mortier, W. (2001) A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology, 57, 2273-2277.
22. Betz, R.C., Schoser, B.G., Kasper, D., Ricker, K., Ramirez, A., Stein, V., Torbergsen, T., Lee, Y.A., Nothen, M. M., Wienker, T. F. et al. (2001) Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat. Genet., 28, 218-219.
23. Carbone, I., Bruno, C., Sotgia, F., Bado, M., Broda, P., Masetti, E., Panella, A., Zara, F., Bricarelli, F.D., Cordone, G. et al. (2000) Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology, 54, 1373-1376.
24. Alias, L., Gallano, P., Moreno, D., Pujol, R., Martinez-Matos, J.A., Baiget, M., Ferrer, I. and Olive, M. (2004) A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia. Neuromuscul. Disord., 14, 321-324.
25. Sugie, K., Murayama, K., Noguchi, S., Murakami, N., Mochizuki, M., Hayashi, Y.K., Nonaka, I. and Nishino, I. (2004) Two novel CAV3 gene mutations in Japanese families. Neuromuscul. Disord., 14 810-814.
26. Cagliani, R., Bresolin, N., Prelle, A., Gallanti, A., Fortunato, F., Sironi, M., Ciscato, P., Fagiolari, G., Bonato, S., Galbiati, S. et al. (2003) A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Neurology, 61, 1513-1519.
27. Van den Bergh, P.Y., Gerard, J.M., Elosegi, J.A., Manta, M.U., Kubisch, C. and Schoser, B.G. (2004) Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease. J. Neurol. Neurosurg. Psychiatry, 75, 1349-1351.
28. Fulizio, L., Chiara Nascimbeni, A., Fanin, M., Piluso, G., Politano, L., Nigro, V. and Angelini, C. (2005) Molecular and muscle pathology in a series of caveolinopathy patients. Hum. Mutat., 25, 82-89.
29. de Paula, F., Vainzof, M., Bernardino, A.L., McNally, E., Kunkel, L.M. and Zatz, M. (2001) Mutations in the caveolin-3 gene: When are they pathogenic? Am. J. Med. Genet., 99, 303-307.
30. Galbiati, F., Volonte, D., Minetti, C., Chu, J.B. and Lisanti, M.P. (1999) Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J. Biol. Chem., 274, 25632-25641.
31. Sunada, Y., Ohi, H., Hase, A., Hosono, T., Arata, S., Higuchi, S., Matsumura, K. and Shimizu, T. (2001) Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum. Mol. Genet., 10, 173-178.
32. Carozzi, A.J., Roy, S., Morrow, I.C., Pol, A., Wyse, B., Clyde-Smith, J., Prior, I.A., Nixon, S.J., Hancock, J.F. and Parton, R.G. (2002) Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin-3. J. Biol. Chem., 277, 17944-17949.
33. Parton, R.G., Way, M., Zorzi, N. and Stang, E. (1997) Caveolin-3 associates with developing T-tubules during muscle differentiation. J. Cell Biol., 136, 137-154.
34. Lee, E., Marcucci, M., Daniell, L., Pypaert, M., Weisz, O.A., Ochoa, G.C., Farsad, K., Wenk, M.R. and De Camilli, P. (2002) Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science, 297, 1193-1196.
35. Volonte, D., Peoples, A.J. and Galbiati, F. (2003) Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C. Mol. Biol. Cell, 14, 4075-4088.
36. Galbiati, F., Volonte, D., Engelman, J.A., Scherer, P.E. and Lisanti, M.P. (1999) Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J. Biol. Chem., 274, 30315-30321.
37. Rahkila, P., Takala, T.E., Parton, R.G. and Metsikko, K. (2001) Protein targeting to the plasma membrane of adult skeletal muscle fiber: An organized mosaic of functional domains. Exp. Cell Res., 267, 61-72.
38. Song, K.S., Scherer, P.E., Tang, Z., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D.S. and Lisanti, M.P. (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem., 271, 15160-15165.
39. Sotgia, F., Lee, J.K., Das, K., Bedford, M., Petrucci, T.C., Macioce, P., Sargiacomo, M., Bricarelli, F.D., Minetti, C., Sudol, M. et al. (2000) Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J. Biol. Chem., 275, 38048-38058.
40. Matsuda, C., Hayashi, Y.K., Ogawa, M., Aoki, M., Murayama, K., Nishino, I., Nonaka, I., Arahata, K. and Brown, R.H., Jr (2001) The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum. Mol. Genet., 10, 1761-1766.
41. Figarella-Branger, D., Pouget, J., Bernard, R., Krahn, M., Fernandez, C., Levy, N. and Pellissier, J.F. (2003) Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene. Neurology, 61, 562-564.
42. Scherer, P.E. and Lisanti, M.P. (1997) Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes. Dynamic regulation by extracellular glucose and intracellular metabolites. J. Biol. Chem., 272, 20698-20705.
43. Venema, V.J., Ju, H., Zou, R. and Venema, R.C. (1997) Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J. Biol. Chem., 272, 28187-28190.
44. Bassett, D.I. and Currie, P.D. (2003) The zebrafish as a model for muscular dystrophy and congenital myopathy. Hum. Mol. Genet., 12 (Suppl. 2), R265-R270.
45. Devoto, S.H., Melancon, E., Eisen, J.S. and Westerfield, M. (1996) Identification of separate slow and fast muscle precursor cells in vivo, prior to somite formation. Development, 122, 3371-3380.
46. Parsons, M.J., Campos, I., Hirst, E.M. and Stemple, D.L. (2002) Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. Development, 129, 3505-3512.
47. Guyon, J.R., Mosley, A.N., Zhou, Y., O'Brien, K.F., Sheng, X., Chiang, K., Davidson, A.J., Volinski, J.M., Zon, L.I. and Kunkel, L.M. (2003) The dystrophin associated protein complex in zebrafish. Hum. Mol. Genet., 12, 601-615.
48. Engelman, J.A., Zhang, X.L., Galbiati, F. and Lisanti, M.P. (1998) Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett., 429, 330-336.
49. Li, S., Couet, J. and Lisanti, M.P. (1996) Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem., 271 29182-29190.
50. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J.E., Hansen, S.H., Nishimoto, I. and Lisanti, M.P. (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem., 270, 15693-15701.
51. Felsenfeld, A.L., Curry, M. and Kimmel, C.B. (1991) The fub-1 mutation blocks initial myofibril formation in zebrafish muscle pioneer cells. Dev. Biol., 148, 23-30.
52. Luetterforst, R., Stang, E., Zorzi, N., Carozzi, A., Way, M. and Parton, R.G. (1999) Molecular characterization of caveolin association with the Golgi complex: Identification of a cis-Golgi targeting domain in the caveolin molecule. J. Cell Biol., 145, 1443-1459.
53. Kogo, H., Aiba, T. and Fujimoto, T. (2004) Cell type-specific occurrence of caveolin-1alpha and -1beta in the lung caused by expression of distinct mRNAs. J. Biol. Chem., 279, 25574-25581.
54. Razani, B., Park, D.S., Miyanaga, Y., Ghatpande, A., Cohen, J., Wang, X.B., Scherer, P.E., Evans, T. and Lisanti, M.P. (2002) Molecular cloning and developmental expression of the caveolin gene family in the amphibian Xenopus laevis. Biochemistry, 41, 7914-7924.
55. Biederer, C.H., Ries, S.J., Moser, M., Florio, M., Israel, M.A., McCormick, F. and Buettner, R. (2000) The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development. J. Biol. Chem., 275, 26245-26251.
56. Weinberg, E.S., Allende, M.L., Kelly, C.S., Abdelhamid, A., Murakami, T., Andermann, P., Doerre, O.G., Grunwald, D.J. and Riggleman, B. (1996) Developmental regulation of zebrafish MyoD in wild-type, no tail and spadetail embryos. Development, 122, 271-280.
57. Stemple, D.L., Solnica-Krezel, L., Zwartkruis, F., Neuhauss, S.C., Schier, A.F., Malicki, J., Stainier, D.Y., Abdelilah, S., Rangini, Z., Mountcastle-Shah, E. et al. (1996) Mutations affecting development of the notochord in zebrafish. Development, 123, 117-128.
58. Aravamudan, B., Volonte, D., Ramani, R., Gursoy, E., London, B. and Galbiati, F. (2003) Transgenic over-expression of caveolin-3 in the heart induces a cardiomyopathic phenotype. Hum. Mol. Genet., 12 2777-2788.
59. Woodman, S.E., Park, D.S., Cohen, A.W., Cheung, M.W., Chandra, M., Shirani, J., Tang, B., Jelicks, L.A., Kitsis, R.N., Christ, G.J. et al. (2002) Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J. Biol. Chem., 277, 38988-38997.
60. Blagden, C.S., Currie, P.D., Ingham, P.W. and Hughes, S.M. (1997) Notochord induction of zebrafish slow muscle mediated by Sonic hedgehog. Genes Dev., 11, 2163-2175.
61. Currie, P.D. and Ingham, P.W. (1996) Induction of a specific muscle cell type by a hedgehog-like protein in zebrafish. Nature, 382, 452-455.
62. Du, S.J., Devoto, S.H., Westerfield, M. and Moon, R.T. (1997) Positive and negative regulation of muscle cell identity by members of the hedgehog and TGF-beta gene families. J. Cell Biol., 139 145-156.
63. Coutelle, O., Blagden, C.S., Hampson, R., Halai, C., Rigby, P.W. and Hughes, S.M. (2001) Hedgehog signalling is required for maintenance of myf5 and myoD expression and timely terminal differentiation in zebrafish adaxial myogenesis. Dev. Biol., 236, 136-150.
64. Barresi, M.J., Stickney, H.L. and Devoto, S.H. (2000) The zebrafish slow-muscle-omitted gene product is required for Hedgehog signal transduction and the development of slow muscle identity. Development 127, 2189-2199.
65. Lewis, K.E., Currie, P.D., Roy, S., Schauerte, H., Haffter, P. and Ingham, P.W. (1999) Control of muscle cell-type specification in the zebrafish embryo by Hedgehog signalling. Dev. Biol., 216, 469-480.
66. Karpen, H.E., Bukowski, J.T., Hughes, T., Gratton, J.P., Sessa, W.C. and Gailani, M.R. (2001) The sonic hedgehog receptor patched associates with caveolin-1 in cholesterol-rich microdomains of the plasma membrane. J. Biol. Chem., 276, 19503-19511.
67. Ingham, P.W. and McMahon, A.P. (2001) Hedgehog signaling in animal development: Paradigms and principles. Genes Dev., 15, 3059-3087.
68. Joliot, A., Trembleau, A., Raposo, G., Calvet, S., Volovitch, M. and Prochiantz, A. (1997) Association of Engrailed homeoproteins with vesicles presenting caveolae-like properties. Development, 124 1865-1875.
69. Westerfield, M. (2000) The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (danio rerio), 4th edn. University of Oregon Press, Eugene.
70. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B. and Schilling, T.F. (1995) Stages of embryonic development of the zebrafish. Dev. Dyn., 203, 253-310.
71. Hukriede, N.A., Joly, L., Tsang, M., Miles, J., Tellis, P., Epstein, J.A., Barbazuk, W.B., Li, F.N., Paw, B., Postlethwait, J.H. et al. (1999) Radiation hybrid mapping of the zebrafish genome. Proc. Natl Acad. Sci. USA, 96, 9745-9750.
72. Thisse, C., Thisse, B., Schilling, T.F. and Postlethwait, J.H. (1993) Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. Development, 119, 1203-1215.
73. Parton, R.G., Molero, J.C., Floetemneyer, M., Green, K.M. and James, D.E. (2002) Characterization of a distinct plasma membrane macrodomain in differentiated adipocytes. J. Biol. Chem., 277, 46769-46778.
74. Smart, E.J., De Rose, R.A. and Farber, S.A. (2004) Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proc. Natl Acad. Sci. USA, 101, 3450-3455.